Home › Funds › Marathon Asset Management Ltd › BIO
Marathon Asset Management Ltd position in BIO
BIO RAD LABS INC · Industrials
Marathon Asset Management Ltd reported holding 38,371 shares of BIO (BIO RAD LABS INC) in its Q3 2026 13F filing — a position valued at US$14.5M, representing 0.66% of its reported portfolio and ranking #44 among its reported holdings. Marathon Asset Management Ltd has disclosed BIO holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Marathon Asset Management Ltd's BIO position evolved
Marathon Asset Management Ltd first disclosed a stake in BIO in Q1 2024 at 75,857 shares (US$26.2M). Across 11 filings, Marathon Asset Management Ltd increased the stake 1 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 38,371 shares valued at US$14.5M — a reduction of -3,604 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 75.86K | $26.24M | New |
| Q2 2024 | 71.19K | $19.44M | Reduce |
| Q3 2024 | 71.54K | $23.93M | Hold |
| Q4 2024 | 67.13K | $22.05M | Reduce |
| Q1 2025 | 60.66K | $14.77M | Reduce |
| Q2 2025 | 59.81K | $14.43M | Reduce |
| Q3 2025 | 51.92K | $14.56M | Reduce |
| Q4 2025 | 47.29K | $14.33M | Reduce |
| Q1 2026 | 53.66K | $14.96M | Add |
| Q2 2026 | 41.98K | $12.32M | Reduce |
| Q3 2026 | 38.37K | $14.49M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIO and 13F data
BIO (BIO RAD LABS INC) is a Industrials company. 25 other funds we track also report a position in BIO — the largest reported positions include First Eagle Investment Management (US$927.5M), ARIEL INVESTMENTS, LLC (US$298.1M), EARNEST PARTNERS LLC (US$214.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIO
- First Eagle Investment Management 2.46M sh · $927.50M · Q3 2026
- ARIEL INVESTMENTS, LLC 789.34K sh · $298.14M · Q3 2026
- EARNEST PARTNERS LLC 567.82K sh · $214.47M · Q3 2026
- First Pacific Advisors, LP 269.08K sh · $101.63M · Q3 2026
- NOMURA HOLDINGS INC 328.90K sh · $96.57M · Q2 2026
More on Marathon Asset Management Ltd
FAQ
How long has Marathon Asset Management Ltd held BIO?
Marathon Asset Management Ltd has disclosed BIO holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Marathon Asset Management Ltd's current position in BIO?
As of Q3 2026, Marathon Asset Management Ltd holds 38.37K shares of BIO (BIO RAD LABS INC), valued at $14.49M, representing 0.66% of its reported portfolio and ranking #44.
Has Marathon Asset Management Ltd been buying or selling BIO?
In the latest 13F filing (Q3 2026), Marathon Asset Management Ltd reduced its position in BIO.
Which other funds hold BIO?
Other major institutional holders of BIO include First Eagle Investment Management, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.